>Novo Nordisk To Offer Weight-Loss Drug At Reduced Price
(Undated) -- The makers of weight-loss drug Wegovy will begin offering the drug directly to patients at a reduced cost. Pharmaceutical company Novo Nordisk announced Wednesday it's starting NovoCare Pharmacy, a program that will offer direct-to-patient sales to underinsured or uninsured customers. The program will sell Wegovy for 499-dollars per month to customers paying cash, an amount much less than the list price of over 13-hundred-dollars. This comes a week after Eli Lilly cut the price of its popular weight-loss drug Zepbound.